In addition, combined PLCγ and MEK inhibition blocked the AZD6244-induced reduction in NF1 expression and reactivation of ERK and simultaneously restored the susceptibility of tumor cells to AZD6244 treatment (Fig. S8C, D). Here, MAP2K7 is linked to neoplasm.